News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
Investigators saw enhanced interleukin-13 production by a handful of immune cell types in mouse models of steroid-resistant asthma.
The startup has launched oncology and pulmonology beta tests at five US health systems, with help from precision health firm mProbe and several pharma partners.
The company's revenue growth was driven by increasing sales of its ePlex molecular diagnostics analyzer, which now has a SARS-CoV-2 test.
Veracyte has obtained rights to a 52-gene signature developed by Yale researchers to predict disease progression in patients with idiopathic pulmonary fibrosis.
The consortium, which spans more than a dozen UK cities, will sequence patient samples to understand the spread and evolution of the novel coronavirus.
